Relationship between neutralizing antibody and liver-mediated factor IX expression in non-human primates using AAV vectors

被引：0
|
作者：
Mizukami, Hiroaki
Mimuro, Jun
Ishiwata, Akira
Ono, Fumiko [1 ]
Yagi, Hiroya
Urabe, Masashi
Kume, Akihiro
Terao, Keiji [1 ]
Yasutomi, Yasuhiro [1 ]
Sakata, Yoichi
Ozawa, Keiya
机构：
[1] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Tsukuba, Ibaraki, Japan
来源：
HUMAN GENE THERAPY | 2009年 / 20卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1481 / 1482
页数：2
相关论文
共 50 条
  • [1] Neutralizing Antibody Affects Liver-Mediated Factor IX Expression in Non-Human Primates by AAV Vectors
    Mizukami, Hiroaki
    Mimuro, Jun
    Ishiwata, Akira
    Ono, Fumiko
    Yagi, Hiroya
    Urabe, Masashi
    Kume, Akihiro
    Terao, Keiji
    Yasutomi, Yasuhiro
    Sakata, Yoichi
    Ozawa, Keiya
    MOLECULAR THERAPY, 2009, 17 : S314 - S315
  • [2] NEUTRALIZING ANTIBODY AGAINST VECTOR CAPSID AFFECTS LIVER-MEDIATED FACTOR IX EXPRESSION IN NON-HUMAN PRIMATES USING AAV VECTORS
    Mizukami, Hiroaki
    Mimuro, Jun
    Ishiwata, Akira
    Ono, Fumiko
    Yagi, Hiroya
    Urabe, Masashi
    Kume, Akihiro
    Terao, Keiji
    Yasutomi, Yasuhiro
    Sakata, Yoichi
    Ozawa, Keiya
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1061 - 1062
  • [3] INHIBITORY ACTIONS OF VERY LOW TITER NEUTRALIZING ANTIBODY AGAINST AAV8 CAPSID UPON LIVER-MEDIATED FACTOR IX EXPRESSION IN NON-HUMAN PRIMATES
    Mizukami, Hiroaki
    Mimuro, Jun
    Ishiwata, Akira
    Ono, Fumiko
    Yagi, Hiroya
    Urabe, Masashi
    Kume, Akihiro
    Terao, Keiji
    Yasutomi, Yasuhiro
    Sakata, Yoichi
    Ozawa, Keiya
    JOURNAL OF GENE MEDICINE, 2009, 11 (12): : 1177 - 1177
  • [4] Liver-mediated factor IX expression by AAV8 vector and pre-existing neutralizing antibody in cynomolgus monkey
    Mizukami, Hiroaki
    Mimuro, Jun
    Ishiwata, Akira
    Ono, Fumiko
    Yagi, Hiroya
    Urabe, Masashi
    Kume, Akihiro
    Keiji, Terao
    Yasutomi, Yasuhiro
    Sakata, Yoichi
    Ozawa, Keiya
    HUMAN GENE THERAPY, 2008, 19 (10) : 1195 - 1196
  • [5] Dose-Response Relationship of Factor IX Expression in Non-Human Primates Following IV Administration of AAV8 Vectors
    Mizukami, Hiroaki
    Mimuro, Jun
    Tsukahara, Tomonori
    Urabe, Masashi
    Kume, Akihiro
    Ohmori, Tsukasa
    Madoiwa, Seiji
    Sakata, Yoichi
    Ozawa, Keiya
    MOLECULAR THERAPY, 2012, 20 : S253 - S253
  • [6] Threshold dose of factor IX expression in non-human primates following IV administration of AAV8 vectors
    Mizukami, Hiroaki
    Mimuro, Jun
    Tsukahara, Tomonori
    Urabe, Masashi
    Kume, Akihiro
    Ohmori, Tsukasa
    Madoiwa, Seiji
    Sakata, Yoichi
    Ozawa, Keiya
    HUMAN GENE THERAPY, 2012, 23 (10) : A77 - A78
  • [7] Circulating Anti-AAV5 Neutralizing Antibody Titers up to 1:1031 Do Not Affect Liver Transduction Efficacy of AAV5 Vectors in Non-Human Primates
    Majowicz, Anna
    Spronck, Lisa
    de Haan, Martin
    Petry, Harald
    Nijmeijer, Bart
    Ferreira, Valerie
    MOLECULAR THERAPY, 2017, 25 (05) : 94 - 94
  • [8] Neutralizing anti-AAV antibody impact on vector transduction following intravitreal administration of AAV in non-human primates
    Shearman, M. S.
    Turunen, H. T.
    Newmark, J.
    Pennock, S.
    Timmers, A.
    HUMAN GENE THERAPY, 2019, 30 (11) : A115 - A116
  • [9] AAV8-Mediated Transgene Expression in Mice and Non-Human Primates
    Mizukami, Hiroaki
    Mimuro, Jun
    Ishiwata, Akira
    Ono, Fumiko
    Matsushita, Takashi
    Okada, Takashi
    Urabe, Masashi
    Kume, Akihiro
    Terao, Keiji
    Sakata, Yoichi
    Ozawa, Keiya
    MOLECULAR THERAPY, 2006, 13 : S3 - S3
  • [10] Therapeutic Factor VIII Expression After AAV Delivery in Non-Human Primates
    Anguela, Xavier M.
    Elkouby, Liron
    Toso, Raffaella
    DiPietro, Marti
    Davidson, Robert J.
    High, Katherine A.
    Sabatino, Denise E.
    MOLECULAR THERAPY, 2016, 24 : S23 - S23
12345